Pacific Biosciences of California PACB Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total Revenue by Product | ||||||
| Consumable revenue | $83.66M+12.3% | $81.94M+16.4% | $79.12M+17.4% | $76.35M+17.9% | $74.49M+17.2% | |
| Instrument revenue | $52.52M-9.1% | $53.82M-18.2% | $51.77M-35.8% | $57.24M-39.1% | $57.77M-47.2% | |
| Total Revenue by Geography | ||||||
| Americas | $73.18M-5.4% | $72.8M-7.5% | $72.26M-21.9% | $74.27M-26.7% | $77.34M-26.0% | |
| Asia-Pacific | $41.27M+4.4% | $43.16M+6.0% | $42.77M-5.7% | $43.92M-8.9% | $39.54M-26.2% | |
| Europe, Middle East and Africa | $45.58M+28.5% | $44.05M+27.3% | $39.56M+11.2% | $37.92M+1.3% | $35.48M-13.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Pacific Biosciences of California break its business down?
- Pacific Biosciences of California (PACB) reports total revenue by product across 3 parts — Consumable revenue, Instrument revenue and Service and other revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does Pacific Biosciences of California's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Pacific Biosciences of California's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
